TECX
TECX
NASDAQ · Biotechnology

Tectonic Therapeutic Inc

$30.59
+0.25 (+0.82%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +21.7% upside
Low Target $31.47
Average Target $37.23
High Target $57.92
Current Price $30.59
Current
$30.59
Target
$37.23
$31.47 $37.23 avg $57.92
Scenario Analysis
Bear Case
$31.47
2.9%
Low target
Base Case
$37.23
+21.7%
Avg target
Bull Case
$57.92
+89.3%
High target
Risk/Reward
31.1x
Highly favorable
Price in Context
52-Week High
$36.03
-15.1% from high
52-Week Low
$14.39
+112.6% from low
Target vs 52W High
$37.23
+3.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +190.0%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -6.4%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.7%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -39.1%